Scavenging the hidden impacts of non-coding RNAs in multiple sclerosis

Dimitrov, 2014, What's new in multiple sclerosis?, Br. J. Gen. Pract., 64, 612, 10.3399/bjgp14X682609 Wallin, 2019, Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet Neurol., 18, 269, 10.1016/S1474-4422(18)30443-5 O'Gorman, 2012, Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms, Int. J. Mol. Sci., 13, 11718, 10.3390/ijms130911718 Lublin, 1996, Defining the clinical course of multiple sclerosis: results of an international survey. National multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis, Neurology, 46, 907, 10.1212/WNL.46.4.907 Lublin, 2014, Defining the clinical course of multiple sclerosis, The 2013 revisions, 83, 278 Constantinescu, 2011, Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS), Br. J. Pharmacol., 164, 1079, 10.1111/j.1476-5381.2011.01302.x Robinson, 2014, The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment, Handb. Clin. Neurol., 122, 173, 10.1016/B978-0-444-52001-2.00008-X Lazibat, 2018, Multiple sclerosis: new aspects of immunopathogenesis, Acta Clin. Croat., 57, 352 Poser, 1986, Pathogenesis of multiple sclerosis. A critical reappraisal, Acta Neuropathol., 71, 1, 10.1007/BF00687954 Mattick, 2006, Non-coding RNA, Hum. Mol. Genet., 15, R17, 10.1093/hmg/ddl046 Dahariya, 2019, Long non-coding RNA: classification, biogenesis and functions in blood cells, Mol. Immunol., 112, 82, 10.1016/j.molimm.2019.04.011 Perron, 2008, Protein interactions and complexes in human microRNA biogenesis and function, Front. Biosci., 13, 2537, 10.2741/2865 Rajewsky, 2006, L(ou)sy miRNA targets?, Nat. Struct. Mol. Biol., 13, 754, 10.1038/nsmb0906-754 Esau, 2006, miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting, Cell Metabol., 3, 87, 10.1016/j.cmet.2006.01.005 Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 Macfarlane, 2010, MicroRNA: biogenesis, function and role in cancer, Curr. Genom., 11, 537, 10.2174/138920210793175895 Ambros, 2003, A uniform system for microRNA annotation, RNA, 9, 277, 10.1261/rna.2183803 Gura, 2000, A silence that speaks volumes, Nature, 404, 804, 10.1038/35009245 Kim, 2014, A guide to genome engineering with programmable nucleases, Nat. Rev. Genet., 15, 321, 10.1038/nrg3686 Scherer, 2003, Approaches for the sequence-specific knockdown of mRNA, Nat. Biotechnol., 21, 1457, 10.1038/nbt915 Otaegui, 2009, Differential micro RNA expression in PBMC from multiple sclerosis patients, PLoS One, 4, 10.1371/journal.pone.0006309 Cox, 2010, MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood, PLoS One, 5, 10.1371/journal.pone.0012132 Keller, 2009, Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls, PLoS One, 4, 10.1371/journal.pone.0007440 Gandhi, 2013, Circulating microRNAs as biomarkers for disease staging in multiple sclerosis, Ann. Neurol., 73, 729, 10.1002/ana.23880 Li, 2014, Soluble beta-amyloid peptides, but not insoluble fibrils, have specific effect on neuronal microRNA expression, PLoS One, 9 Lindberg, 2010, Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients, Eur. J. Immunol., 40, 888, 10.1002/eji.200940032 Liu, 2014, miR-17-92 cluster targets phosphatase and tensin homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation, J. Biol. Chem., 289, 12446, 10.1074/jbc.M114.550723 Junker, 2009, MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47, Brain, 132, 3342, 10.1093/brain/awp300 De Santis, 2010, Altered miRNA expression in T regulatory cells in course of multiple sclerosis, J. Neuroimmunol., 226, 165, 10.1016/j.jneuroim.2010.06.009 Du, 2009, MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis, Nat. Immunol., 10, 1252, 10.1038/ni.1798 Thamilarasan, 2012, MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis, Autoimmun. Rev., 11, 174, 10.1016/j.autrev.2011.05.009 Zhang, 2018, miR-23b suppresses leukocyte migration and pathogenesis of experimental autoimmune encephalomyelitis by targeting CCL7, Mol. Ther., 26, 582, 10.1016/j.ymthe.2017.11.013 Liu, 2019, MiR-409-3p and MiR-1896 co-operatively participate in IL-17-induced inflammatory cytokine production in astrocytes and pathogenesis of EAE mice via targeting SOCS3/STAT3 signaling, Glia, 67, 101, 10.1002/glia.23530 Zhu, 2019, miR-140-5p regulates T cell differentiation and attenuates experimental autoimmune encephalomyelitis by affecting CD4(+)T cell metabolism and DNA methylation, Int. Immunopharm., 75, 105778, 10.1016/j.intimp.2019.105778 Finardi, 2020, Mir106b-25 and mir17-92 are crucially involved in the development of experimental neuroinflammation, Front. Neurol., 11, 912, 10.3389/fneur.2020.00912 Song, 2020, Protective effect of microRNA-134-3p on multiple sclerosis through inhibiting PRSS57 and promotion of CD34(+) cell proliferation in rats, J. Cell. Biochem., 121, 4347, 10.1002/jcb.29643 Long, 2020, MiR-125a-5p regulates vitamin D receptor expression in a mouse model of experimental autoimmune encephalomyelitis, Neurosci Bull, 36, 110, 10.1007/s12264-019-00418-0 Duffy, 2020, The role of MicroRNAs in repair processes in multiple sclerosis, Cells, 9, 1711, 10.3390/cells9071711 Marangon, 2020, In vivo silencing of miR-125a-3p promotes myelin repair in models of white matter demyelination, Glia, 68, 2001, 10.1002/glia.23819 Tripathi, 2019, Oligodendrocyte intrinsic miR-27a controls myelination and remyelination, Cell Rep., 29, 904, 10.1016/j.celrep.2019.09.020 Reijerkerk, 2013, MicroRNAs regulate human brain endothelial cell-barrier function in inflammation: implications for multiple sclerosis, J. Neurosci., 33, 6857, 10.1523/JNEUROSCI.3965-12.2013 Talebi, 2017, MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis, J. Neuroinflammation, 14, 55, 10.1186/s12974-017-0832-7 Muñoz-San Martín, 2019, Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a/b in patients with multiple sclerosis and active lesions, J. Neuroinflammation, 16, 220, 10.1186/s12974-019-1590-5 Kramer, 2019, Elevated levels of miR-181c and miR-633 in the CSF of patients with MS: a validation study, Neurol Neuroimmunol Neuroinflamm, 6, 10.1212/NXI.0000000000000623 Kimura, 2018, Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis, Nat. Commun., 9, 17, 10.1038/s41467-017-02406-2 Ibrahim, 2020, Serum ROCK2, miR-300 and miR-450b-5p levels in two different clinical phenotypes of multiple sclerosis: relation to patient disability and disease progression, J. Neuroimmunol., 347 Zanoni, 2020, Upregulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients, Acta Neurol. Scand., 142, 511, 10.1111/ane.13288 Shademan, 2020, Investigation of the miRNA146a and miRNA155 gene expression levels in patients with multiple sclerosis, J. Clin. Neurosci., 78, 189, 10.1016/j.jocn.2020.04.071 Luo, 2018, Identifying characteristic miRNAs-genes and risk pathways of multiple sclerosis based on bioinformatics analysis, Oncotarget, 9, 5287, 10.18632/oncotarget.23866 Yang, 2017, Identification of the miRNA–mRNA regulatory network in multiple sclerosis, Neurol. Res., 39, 142, 10.1080/01616412.2016.1250857 Martinelli-Boneschi, 2012, MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers, Neurosci. Lett., 508, 4, 10.1016/j.neulet.2011.11.006 Sanders, 2016, Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells, Clin. Epigenet., 8, 87, 10.1186/s13148-016-0253-y Alizadeh-Fanalou, 2020, Dysregulation of microRNAs regulating survivin in CD4+ T cells in multiple sclerosis, Mult Scler Relat Disord, 44, 10.1016/j.msard.2020.102303 Amoruso, 2020, Immune and central nervous system-related miRNAs expression profiling in monocytes of multiple sclerosis patients, Sci. Rep., 10, 6125, 10.1038/s41598-020-63282-3 Bazin, 2017, vol. 114, E10018 Wang, 2017, Global and cell-type specific properties of lincRNAs with ribosome occupancy, Nucleic Acids Res., 45, 2786 Gibb, 2011, The functional role of long non-coding RNA in human carcinomas, Mol. Cancer, 10, 38, 10.1186/1476-4598-10-38 Guo, 2017, Involvement of lncRNA-1700040D17Rik in Th17 cell differentiation and the pathogenesis of EAE, Int. Immunopharm., 47, 141, 10.1016/j.intimp.2017.03.014 Masoumi, 2019, Malat1 long noncoding RNA regulates inflammation and leukocyte differentiation in experimental autoimmune encephalomyelitis, J. Neuroimmunol., 328, 50, 10.1016/j.jneuroim.2018.11.013 Yue, 2019, Down-regulation of taurine-up-regulated gene 1 attenuates inflammation by sponging miR-9-5p via targeting NF-kappaB1/p50 in multiple sclerosis, Life Sci., 233, 10.1016/j.lfs.2019.116731 Bian, 2020, Gm15575 functions as a ceRNA to upregulate CCL7 expression through sponging miR-686 in Th17 cells, Mol. Immunol., 125, 32, 10.1016/j.molimm.2020.06.027 Shaker, 2019, LncRNAs, MALAT1 and lnc-DC as potential biomarkers for multiple sclerosis diagnosis, Biosci. Rep., 39, 10.1042/BSR20181335 Santoro, 2016, Expression profile of long non-coding RNAs in serum of patients with multiple sclerosis, J. Mol. Neurosci., 59, 18, 10.1007/s12031-016-0741-8 Santoro, 2020, A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients, Eur. Rev. Med. Pharmacol. Sci., 24, 3267 Senousy, 2020, LncRNA GAS5 and miR-137 polymorphisms and expression are associated with multiple sclerosis risk: mechanistic insights and potential clinical impact, ACS Chem. Neurosci., 11, 1651, 10.1021/acschemneuro.0c00150 Zhang, 2018, DDIT4 and associated lncDDIT4 modulate Th17 differentiation through the DDIT4/TSC/mTOR pathway, J. Immunol., 200, 1618, 10.4049/jimmunol.1601689 Sun, 2017, LncRNA GAS5 inhibits microglial M2 polarization and exacerbates demyelination, EMBO Rep., 18, 1801, 10.15252/embr.201643668 Zhang, 2017, Linc-MAF-4 regulates Th1/Th2 differentiation and is associated with the pathogenesis of multiple sclerosis by targeting MAF, FASEB (Fed. Am. Soc. Exp. Biol.) J., 31, 519 Li, 2018, LncRNAs on guard, Int. Immunopharm., 65, 60, 10.1016/j.intimp.2018.09.031 Zhang, 2017, Linc-MAF-4 regulates Th1/Th2 differentiation and is associated with the pathogenesis of multiple sclerosis by targeting MAF, Faseb. J., 31, 519, 10.1096/fj.201600838R Cardamone, 2019, Not only cancer: the long non-coding RNA MALAT1 affects the repertoire of alternatively spliced transcripts and circular RNAs in multiple sclerosis, Hum. Mol. Genet., 28, 1414, 10.1093/hmg/ddy438 Dastmalchi, 2018, Dysregulation of long non-coding RNA profile in peripheral blood of multiple sclerosis patients, Mult Scler Relat Disord, 25, 219, 10.1016/j.msard.2018.07.044 Eftekharian, 2017, Expression analysis of long non-coding RNAs in the blood of multiple sclerosis patients, J. Mol. Neurosci., 63, 333, 10.1007/s12031-017-0982-1 Bahrami, 2020, Expression analysis of long non-coding RNA lnc-DC in HLA-DRB1*15:01-negative patients with multiple sclerosis: a probable cause for gender differences in multiple sclerosis susceptibility?, J. Mol. Neurosci., 71, 821, 10.1007/s12031-020-01704-7 Ghaiad, 2020, Long noncoding RNAs APOA1-AS, IFNG-AS1, RMRP and their related biomolecules in Egyptian patients with relapsing-remitting multiple sclerosis: relation to disease activity and patient disability, J. Adv. Res., 21, 141, 10.1016/j.jare.2019.10.012 Patoughi, 2021, Expression analysis of PINK1 and PINK1-AS in multiple sclerosis patients versus healthy subjects, Nucleos Nucleot. Nucleic Acids, 40, 157 Patoughi, 2019, GAS8 and its naturally occurring antisense RNA as biomarkers in multiple sclerosis, Immunobiology, 224, 560, 10.1016/j.imbio.2019.04.005 Shaker, 2020, Correlation between LincR-Gng2-5'and LincR-Epas1-3'as with the severity of multiple sclerosis in Egyptian patients, Int. J. Neurosci., 130, 515, 10.1080/00207454.2019.1695610 Safa, 2020, Dysregulation of NF-κB-Associated lncRNAs in multiple sclerosis patients, J. Mol. Neurosci., 71, 80, 10.1007/s12031-020-01628-2 Moradi, 2020, Evaluation of the expression levels of three long non-coding RNAs in multiple sclerosis, Cell J, 22, 165 Safa, 2020, Downregulation of cancer-associated lncRNAs in peripheral blood of multiple sclerosis patients, J. Mol. Neurosci., 70, 1533, 10.1007/s12031-020-01646-0 Zurawska, 2019, Circular RNAs as a novel layer of regulatory mechanism in multiple sclerosis, J. Neuroimmunol., 334, 576971, 10.1016/j.jneuroim.2019.576971 Iparraguirre, 2017, Circular RNA profiling reveals that circular RNAs from ANXA2 can be used as new biomarkers for multiple sclerosis, Hum. Mol. Genet., 26, 3564, 10.1093/hmg/ddx243 Cardamone, 2017, The characterization of GSDMB splicing and backsplicing profiles identifies novel isoforms and a circular RNA that are dysregulated in multiple sclerosis, Int. J. Mol. Sci., 18, 10.3390/ijms18030576 Paraboschi, 2018, Interpreting non-coding genetic variation in multiple sclerosis genome-wide associated regions, Front. Genet., 9, 647, 10.3389/fgene.2018.00647 Iparraguirre, 2020, RNA-Seq profiling of leukocytes reveals a sex-dependent global circular RNA upregulation in multiple sclerosis and 6 candidate biomarkers, Hum. Mol. Genet., 29, 3361, 10.1093/hmg/ddaa219 Iparraguirre, 2020, Whole-Transcriptome analysis in peripheral blood mononuclear cells from patients with lipid-specific oligoclonal IgM band characterization reveals two circular RNAs and two linear RNAs as biomarkers of highly active disease, Biomedicines, 8, 10.3390/biomedicines8120540 Han, 2021, The circular RNA circINPP4B acts as a sponge of miR-30a to regulate Th17 cell differentiation during progression of experimental autoimmune encephalomyelitis, Cell. Mol. Immunol., 18, 2177, 10.1038/s41423-021-00748-y Zhang, 2018, MicroRNA-181c promotes Th17 cell differentiation and mediates experimental autoimmune encephalomyelitis, Brain Behav. Immun., 70, 305, 10.1016/j.bbi.2018.03.011 Murugaiyan, 2015, MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis, J. Clin. Invest., 125, 1069, 10.1172/JCI74347 Naghavian, 2015, miR-141 and miR-200a, revelation of new possible players in modulation of Th17/Treg differentiation and pathogenesis of multiple sclerosis, PLoS One, 10, 10.1371/journal.pone.0124555 Severin, 2016, MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis, Brain, 139, 1747, 10.1093/brain/aww084 Li, 2019, Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis, Aging (Albany NY), 11, 4463, 10.18632/aging.102093 Zhu, 2014, miR-20b suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis by targeting RORgammat and STAT3, J. Immunol., 192, 5599, 10.4049/jimmunol.1303488 Mycko, 2012, MicroRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination, Proc. Natl. Acad. Sci. U. S. A., 109, E1248, 10.1073/pnas.1114325109 Wu, 2020, vol. 1934, 11 Yang, 2017, Long noncoding RNA MALAT-1 is a novel inflammatory regulator in human systemic lupus erythematosus, Oncotarget, 8, 77400, 10.18632/oncotarget.20490 Li, 2018, Long non-coding RNAs in rheumatoid arthritis, Cell Prolif, 51, 10.1111/cpr.12404 Keller, 2014, Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing, Mult. Scler., 20, 295, 10.1177/1352458513496343 Nuzziello, 2018, Investigating the role of MicroRNA and transcription factor Co-regulatory networks in multiple sclerosis pathogenesis, Int. J. Mol. Sci., 19, 10.3390/ijms19113652 Mahmoud, 2017, MicroRNA 26a expression in peripheral blood mononuclear cells and correlation with serum interleukin-17 in relapsing-remitting multiple sclerosis patients, Egypt. J. Immunol., 24, 71 Zhang, 2015, miR26a modulates Th17/T reg balance in the EAE model of multiple sclerosis by targeting IL6, NeuroMolecular Med., 17, 24, 10.1007/s12017-014-8335-5 Bergman, 2016, Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis, Neurol Neuroimmunol Neuroinflamm, 3, e219, 10.1212/NXI.0000000000000219 Tavakolpour, 2018, Increased expression of mir-301a in PBMCs of patients with relapsing-remitting multiple sclerosis is associated with reduced NKRF and PIAS3 expression levels and disease activity, J. Neuroimmunol., 325, 79, 10.1016/j.jneuroim.2018.10.002 Selmaj, 2017, Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis, Ann. Neurol., 81, 703, 10.1002/ana.24931 Niwald, 2017, Evaluation of selected MicroRNAs expression in remission phase of multiple sclerosis and their potential link to cognition, depression, and disability, J. Mol. Neurosci., 63, 275, 10.1007/s12031-017-0977-y Tahmasebivand, 2020, miR-504 expression level is increased in multiple sclerosis patients responder to interferon-beta, J. Neuroimmunol., 342, 10.1016/j.jneuroim.2020.577212 Mazdeh, 2020, Assessment of expression profile of microRNAs in multiple sclerosis patients treated with fingolimod, J. Mol. Neurosci., 70, 1274, 10.1007/s12031-020-01537-4 Fattahi, 2020, Comparison of the expression of miR-326 between interferon beta responders and non-responders in relapsing-remitting multiple sclerosis, Cell J, 22, 92 Ifergan, 2016, Cutting edge: MicroRNA-223 regulates myeloid dendritic cell-driven Th17 responses in experimental autoimmune encephalomyelitis, J. Immunol., 196, 1455, 10.4049/jimmunol.1501965 Wan, 2016, MicroRNA 182 inhibits CD4+ CD25+ Foxp3+ Treg differentiation in experimental autoimmune encephalomyelitis, Clin. Immunol., 173, 109, 10.1016/j.clim.2016.09.008 Liu, 2017, MicroRNA-590 promotes pathogenic Th17 cell differentiation through targeting Tob1 and is associated with multiple sclerosis, Biochem. Biophys. Res. Commun., 493, 901, 10.1016/j.bbrc.2017.09.123 Wu, 2017, MicroRNA-448 promotes multiple sclerosis development through induction of Th17 response through targeting protein tyrosine phosphatase non-receptor type 2 (PTPN2), Biochem. Biophys. Res. Commun., 486, 759, 10.1016/j.bbrc.2017.03.115 Guan, 2013, MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis, Eur. J. Immunol., 43, 104, 10.1002/eji.201242702 Ahmadian-Elmi, 2016, miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis, Immunogenetics, 68, 43, 10.1007/s00251-015-0881-y Liu, 2017, MicroRNA-15b suppresses Th17 differentiation and is associated with pathogenesis of multiple sclerosis by targeting O-GlcNAc transferase, J. Immunol., 198, 2626, 10.4049/jimmunol.1601727 Hanieh, 2013, MicroRNA-132 suppresses autoimmune encephalomyelitis by inducing cholinergic anti-inflammation: a new Ahr-based exploration, Eur. J. Immunol., 43, 2771, 10.1002/eji.201343486 Li, 2017, miR-146a modulates autoreactive Th17 cell differentiation and regulates organ-specific autoimmunity, J. Clin. Invest., 127, 3702, 10.1172/JCI94012 Cerutti, 2017, MiR-126 and miR-126* regulate shear-resistant firm leukocyte adhesion to human brain endothelium, Sci. Rep., 7, 10.1038/srep45284 Qu, 2016, MiR-30a inhibits Th17 differentiation and demyelination of EAE mice by targeting the IL-21R, Brain Behav. Immun., 57, 193, 10.1016/j.bbi.2016.03.016 Qu, 2017, MiR-384 regulates the Th17/Treg ratio during experimental autoimmune encephalomyelitis pathogenesis, Front. Cell. Neurosci., 11, 88, 10.3389/fncel.2017.00088 Ichiyama, 2016, The MicroRNA-183-96-182 cluster promotes T helper 17 cell pathogenicity by negatively regulating transcription factor Foxo1 expression, Immunity, 44, 1284, 10.1016/j.immuni.2016.05.015 Angelou, 2019, Differentiation of pathogenic Th17 cells is negatively regulated by let-7 MicroRNAs in a mouse model of multiple sclerosis, Front. Immunol., 10, 3125, 10.3389/fimmu.2019.03125 Han, 2019, STAT3 regulates miR-384 transcription during Th17 polarization, Front Cell Dev Biol, 7, 253, 10.3389/fcell.2019.00253 Wan, 2019, MicroRNA 182 promotes T helper 1 cell by repressing hypoxia induced factor 1 alpha in experimental autoimmune encephalomyelitis, Eur. J. Immunol., 49, 2184, 10.1002/eji.201948111 Manna, 2018, Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients, Faseb. J., 32, 4241, 10.1096/fj.201701533R Ahlbrecht, 2016, Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis, Mult. Scler., 22, 1202, 10.1177/1352458515613641 Mancuso, 2015, MicroRNA-572 expression in multiple sclerosis patients with different patterns of clinical progression, J. Transl. Med., 13, 148, 10.1186/s12967-015-0504-2 Vistbakka, 2018, Evaluation of serum miR-191-5p, miR-24-3p, miR-128-3p, and miR-376c-3 in multiple sclerosis patients, Acta Neurol. Scand., 138, 130, 10.1111/ane.12921 Bruinsma, 2017, Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MS, J. Neuroinflammation, 14, 235, 10.1186/s12974-017-1006-3 Sedeeq, 2019, Micro-RNA-96 and interleukin-10 are independent biomarkers for multiple sclerosis activity, J. Neurol. Sci., 403, 92, 10.1016/j.jns.2019.06.022 Mohamed, 2019, Micro-RNA 18b and interleukin 17A profiles in relapsing remitting multiple sclerosis, Mult Scler Relat Disord, 28, 226, 10.1016/j.msard.2018.12.013 Rahimirad, 2021 Teimuri, 2018, Integrative analysis of lncRNAs in Th17 cell lineage to discover new potential biomarkers and therapeutic targets in autoimmune diseases, Mol. Ther. Nucleic Acids, 12, 393, 10.1016/j.omtn.2018.05.022 Hosseini, 2019, LncRNAs associated with multiple sclerosis expressed in the Th1 cell lineage, J. Cell. Physiol., 234, 22153, 10.1002/jcp.28779 Liu, 2018, Analysis of long noncoding RNA and mRNA expression profiles in IL-9-activated astrocytes and EAE mice, Cell. Physiol. Biochem., 45, 1986, 10.1159/000487975 Ghoveud, 2020, Potential biomarker and therapeutic LncRNAs in multiple sclerosis through targeting memory B cells, NeuroMolecular Med., 22, 111, 10.1007/s12017-019-08570-6 Gharesouran, 2019, Integrative analysis of OIP5-AS1/HUR1 to discover new potential biomarkers and therapeutic targets in multiple sclerosis, J. Cell. Physiol., 234, 17351, 10.1002/jcp.28355 Ganji, 2019, Expression analysis of long non-coding RNAs and their target genes in multiple sclerosis patients, Neurol. Sci., 40, 801, 10.1007/s10072-019-3720-3 Sayad, 2019, Hepatocellular carcinoma upregulated long non-coding RNA: a putative marker in multiple sclerosis, Metab. Brain Dis., 34, 1201, 10.1007/s11011-019-00418-z